title: NCCN's Commitment to Medication Safety: The Vincristine Initiative.
abstract: The mission of NCCN is to improve the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Improving medication safety is an important aspect of fulfilling this mission. In September 2014, the NCCN Best Practices Committee began a medication safety initiative to improve the safe use of vincristine. This article describes and discusses this initiative.
authors: From NCCN, Fort Washington, Pennsylvania, and Seattle Cancer Care Alliance, Seattle, Washington.
authors: Jessica
authors: J
authors: Sugalski
authors: From NCCN, Fort Washington, Pennsylvania, and Seattle Cancer Care Alliance, Seattle, Washington.
authors: F Marc
authors: FM
authors: Stewart
authors: From NCCN, Fort Washington, Pennsylvania, and Seattle Cancer Care Alliance, Seattle, Washington.
authors: Robert W
authors: RW
authors: Carlson
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D014750:Vincristine